CELL.MICELL.MIMIL
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +1.99% | -48.75% | +10.97% | -13.70% | -5.30% |
| Gross Profit Growth | -0.52% | -37.62% | +54.96% | +6.59% | -20.54% |
| EBITDA Growth | -2.90% | -13.45% | +86.26% | -66.61% | -12.04% |
| Operating Income Growth | -17.09% | +43.21% | +0.00% | -114.14% | -6.02% |
| Net Income Growth | -35.78% | +16.15% | +0.00% | -152.87% | -10.71% |
| EPS Growth | -35.29% | +16.67% | +0.00% | -153.79% | -9.09% |
| EPS Diluted Growth | -35.29% | +16.67% | +0.00% | -153.79% | -9.09% |
| Weighted Average Shares Growth | +2.37% | +2.08% | -1.27% | -1.84% | -3.16% |
| Weighted Average Shares Diluted Growth | +1.56% | -0.19% | -1.27% | -1.85% | -2.39% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +4.09% | -55.04% | -24.16% | +10.70% | -8.30% |
| Free Cash Flow Growth | -18.37% | -56.65% | -32.51% | +22.13% | +8.40% |
| Receivables Growth | -9.88% | +10.15% | -5.67% | -15.35% | -11.87% |
| Inventory Growth | -16.10% | -15.45% | +3.12% | +10.33% | +1.12% |
| Asset Growth | -2.17% | -3.22% | -1.04% | +0.89% | -5.19% |
| Book Value per Share Growth | -0.21% | -0.29% | +2.92% | +3.39% | +3.89% |
| Debt Growth | +5.21% | -13.39% | -5.00% | +12.62% | -10.95% |
| R&D Expense Growth | -5.70% | +7.91% | +0.00% | +0.00% | -100.00% |
| SG&A Expenses Growth | -52.22% | +1.58% | -1.18% | -0.44% | -25.62% |